Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity

Secreted frizzled-related protein 5 (SFRP5) is an anti-inflammatory adipocytokine secreted by adipocytes that seems to be linked with nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the role of the SFRP5-wingless-MMTV integration site family member 5a (WNT5A) pathway, closely related to adipogenesis, in subcutaneous (SAT) and visceral adipose tissues (VAT) and its relationship with obesity-related NAFLD. Our cohort was composed of 60 women with morbid obesity (MO), who underwent hypocaloric diet, subclassified according to their hepatic histopathology and 15 women with normal weight. We observed increased SFRP5 mRNA expression in VAT and lower WNT5A expression in SAT in MO compared to normal weight. We found elevated SFRP5 expression in nonalcoholic steatohepatitis (NASH) in SAT and in mild simple steatosis (SS) and NASH in VAT. We observed higher WNT5A expression in SS compared to normal liver in SAT, and a peak of WNT5A expression in mild SS. To conclude, we reported increased SFRP5 mRNA expression in SAT and VAT of NAFLD-related to obesity subjects, suggesting an implication of the SFRP5-WNT5A pathway in NAFLD pathogenesis, probably due to the adipose tissue-liver axis. Since the mechanisms by which this potential interaction takes place remain elusive, more research in this field is needed.

[1]  R. González-Sarmiento,et al.  PPAR-γ Gene Expression in Human Adipose Tissue Is Associated with Weight Loss After Sleeve Gastrectomy , 2021, Journal of Gastrointestinal Surgery.

[2]  Chaodong Wu,et al.  Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease , 2021, Cells.

[3]  Bin Gao,et al.  Targeting adipose tissue to tackle NASH: SPARCL1 as an emerging player. , 2021, The Journal of clinical investigation.

[4]  J. Vidal,et al.  A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity , 2021, International journal of molecular sciences.

[5]  Yuping Zhang,et al.  PPARγ attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p/SFRP5 pathway , 2021, Molecular medicine reports.

[6]  Anuradha Kalita,et al.  The role of Wnt pathway in obesity induced inflammation and diabetes: a review , 2021, Journal of Diabetes & Metabolic Disorders.

[7]  F. Bacopoulou,et al.  The Emerging Role of Sfrp5 and Wnt5a in the Pathogenesis of Obesity: Implications for a Healthy Diet and Lifestyle , 2021, Nutrients.

[8]  C. Richart,et al.  Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity , 2021, International journal of molecular sciences.

[9]  Kenneth A. Philbrick,et al.  Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease , 2021, Journal of clinical medicine.

[10]  S. Klein,et al.  Associations among adipose tissue immunology, inflammation and exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease. , 2021, Gastroenterology.

[11]  N. Arfian,et al.  Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. , 2021, The Medical journal of Malaysia.

[12]  G. Wu,et al.  Liver and serum adiponectin levels in non‐alcoholic fatty liver disease , 2021, Journal of digestive diseases.

[13]  R. Nusse,et al.  Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis , 2021, Frontiers in Cell and Developmental Biology.

[14]  O. MacDougald,et al.  Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells , 2020, Molecular metabolism.

[15]  Hongliang Li,et al.  Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. , 2020, Free radical biology & medicine.

[16]  M. Allison,et al.  Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease. , 2020, Gastroenterology.

[17]  T. Cotter,et al.  NAFLD 2020: The State of the Disease. , 2020, Gastroenterology.

[18]  P. Dandona,et al.  Macronutrient Mediated Inflammation and Oxidative Stress: Relevance to Insulin Resistance, Obesity and Atherogenesis. , 2019, The Journal of clinical endocrinology and metabolism.

[19]  Hongting Zheng,et al.  Central Sfrp5 regulates hepatic glucose flux and VLDL- triglyceride secretion. , 2019, Metabolism: clinical and experimental.

[20]  Y. Lecarpentier,et al.  Multiple Targets of the Canonical WNT/β-Catenin Signaling in Cancers , 2019, Front. Oncol..

[21]  N. Borruel,et al.  Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. , 2019, Autoimmunity reviews.

[22]  M. Kjaer,et al.  An anti-inflammatory phenotype in visceral adipose tissue of old lean mice, augmented by exercise , 2019, Scientific Reports.

[23]  S. Altay,et al.  The Relationship Between Gender Differences and Abnormal Adipokine Profile for Cardiometabolic Risk Indicators , 2019, Balkan medical journal.

[24]  B. Mittal Subcutaneous adipose tissue & visceral adipose tissue , 2019, The Indian journal of medical research.

[25]  Gangyi Yang,et al.  Sfrp5 interacts with Slurp1 to regulate the accumulation of triglycerides in hepatocyte steatosis model. , 2019, Biochemical and biophysical research communications.

[26]  M. Moreno-Aliaga,et al.  Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation , 2019, Nutrients.

[27]  A. Nencioni,et al.  Resistin: A reappraisal , 2019, Mechanisms of Ageing and Development.

[28]  Y. Klimentidis,et al.  The E3 ubiquitin ligase MARCH1 regulates glucose-tolerance and lipid storage in a sex-specific manner , 2018, PloS one.

[29]  Jun Li,et al.  Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis. , 2018, Gene.

[30]  Shuang Song,et al.  Downregulation of Sfrp5 in insulin resistant rats promotes macrophage-mediated pulmonary inflammation through activation of Wnt5a/JNK1 signaling. , 2018, Biochemical and biophysical research communications.

[31]  Ji-qiu Wang,et al.  Wnt/β-Catenin Signaling and Obesity , 2018, Front. Physiol..

[32]  B. Neuschwander‐Tetri,et al.  Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.

[33]  Qing Zhu,et al.  The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus , 2018, Bioscience reports.

[34]  L. Joosten,et al.  IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies. , 2018, Trends in molecular medicine.

[35]  P. Scherer,et al.  Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization , 2018, Molecular and Cellular Biology.

[36]  K. Kowdley,et al.  Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. , 2018, Clinics in liver disease.

[37]  W. Tian,et al.  Wnt5a regulates the cell proliferation and adipogenesis via MAPK‐independent pathway in early stage of obesity , 2018, Cell biology international.

[38]  C. Apovian,et al.  Activation of non-canonical WNT signaling in human visceral adipose tissue contributes to local and systemic inflammation , 2017, Scientific Reports.

[39]  Gangyi Yang,et al.  Plasma Sfrp5 levels correlate with determinants of the metabolic syndrome in Chinese adults , 2017, Diabetes/metabolism research and reviews.

[40]  Linuo Zhou,et al.  Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis , 2017, Nutrition & Metabolism.

[41]  A. Xu,et al.  Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease , 2017, Chinese Journal of Integrative Medicine.

[42]  Joseph M Pappachan,et al.  Non-alcoholic Fatty Liver Disease: A Clinical Update , 2017, Journal of clinical and translational hepatology.

[43]  L. Beilin,et al.  Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults , 2017, Biology of Sex Differences.

[44]  L. Beljaars,et al.  RESEARCH Liver and Biliary Tract Physiology/Pathophysiology WNT-5A regulates TGF- (cid:2) -related activities in liver fibrosis , 2017 .

[45]  A. Sanyal,et al.  Therapies in non‐alcoholic steatohepatitis (NASH) , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[46]  Shinsuke Akita,et al.  Human adipocytes from the subcutaneous superficial layer have greater adipogenic potential and lower PPAR-γ DNA methylation levels than deep layer adipocytes. , 2016, American journal of physiology. Cell physiology.

[47]  F. Novelli,et al.  The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. , 2016, Clinical science.

[48]  C. Richart,et al.  Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women , 2015, International journal of molecular sciences.

[49]  Y. Kim,et al.  Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease , 2015, Medicine.

[50]  J. Mann,et al.  Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells , 2015, PloS one.

[51]  C. Aguilar-Salinas,et al.  SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women. , 2015, Annals of hepatology.

[52]  N. Ouchi,et al.  Secreted frizzled‐related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[53]  M. Fasshauer,et al.  Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity , 2015, PloS one.

[54]  Weiqing Wang,et al.  SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis. , 2014, Journal of molecular endocrinology.

[55]  S. Rutz,et al.  The IL-20 subfamily of cytokines — from host defence to tissue homeostasis , 2014, Nature Reviews Immunology.

[56]  K. Walsh,et al.  Noncanonical Wnt Signaling Promotes Obesity-Induced Adipose Tissue Inflammation and Metabolic Dysfunction Independent of Adipose Tissue Expansion , 2014, Diabetes.

[57]  Yanfeng Xiao,et al.  SFRP5 correlates with obesity and metabolic syndrome and increases after weight loss in children , 2014, Clinical endocrinology.

[58]  G. Frühbeck,et al.  Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation. , 2014, The Journal of clinical endocrinology and metabolism.

[59]  A. López-Bermejo,et al.  Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children , 2014, Pediatric Research.

[60]  W. Ouyang,et al.  Therapeutic opportunities of the IL-22–IL-22R1 system , 2013, Nature Reviews Drug Discovery.

[61]  P. Scherer,et al.  Tracking adipogenesis during white adipose tissue development, expansion and regeneration , 2013, Nature Medicine.

[62]  J. M. Suh,et al.  PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.

[63]  K. Ueno,et al.  The effect of sex hormones on peroxisome proliferator-activated receptor gamma expression and activity in mature adipocytes. , 2013, Biological & pharmaceutical bulletin.

[64]  A. Diehl,et al.  The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis. , 2013, The Journal of clinical investigation.

[65]  M. Pagliassotti,et al.  Metabolic alterations following visceral fat removal and expansion , 2012, Adipocyte.

[66]  S. Cinti The adipose organ at a glance , 2012, Disease Models & Mechanisms.

[67]  S. Mandrup,et al.  Lighting the fat furnace without SFRP5. , 2012, The Journal of clinical investigation.

[68]  Hiroyuki Mori,et al.  Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. , 2012, The Journal of clinical investigation.

[69]  Y. Chawla,et al.   Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). , 2012, Annals of hepatology.

[70]  M. Laudes,et al.  Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects , 2012, PloS one.

[71]  D. Goulis,et al.  Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. , 2011, Metabolism: clinical and experimental.

[72]  Yuichi Akasaki,et al.  Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity , 2010, Science.

[73]  A. Ayad,et al.  Serum resistin levels in nonalcoholic fatty liver disease and their relationship to severity of liver disease , 2010 .

[74]  C. Mantzoros,et al.  Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. , 2010, European journal of endocrinology.

[75]  U. Smith,et al.  Activation of Canonical Wingless-type MMTV Integration Site Family (Wnt) Signaling in Mature Adipocytes Increases β-Catenin Levels and Leads to Cell Dedifferentiation and Insulin Resistance* , 2010, The Journal of Biological Chemistry.

[76]  F. Karpe,et al.  Gluteofemoral body fat as a determinant of metabolic health , 2010, International Journal of Obesity.

[77]  D. Langin,et al.  Adipokines and dietary interventions in human obesity , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[78]  M. Ibrahim Subcutaneous and visceral adipose tissue: structural and functional differences , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[79]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[80]  Ichiro Takada,et al.  Wnt and PPARγ signaling in osteoblastogenesis and adipogenesis , 2009, Nature Reviews Rheumatology.

[81]  W. Cawthorn,et al.  Dact1, a Nutritionally Regulated Preadipocyte Gene, Controls Adipogenesis by Coordinating the Wnt/β-Catenin Signaling Network , 2009, Diabetes.

[82]  Antonio Vidal-Puig,et al.  Adipogenesis and WNT signalling , 2009, Trends in Endocrinology & Metabolism.

[83]  M. Kasuga,et al.  Diet-induced up-regulation of gene expression in adipocytes without changes in DNA methylation. , 2008, The Kobe journal of medical sciences.

[84]  J. Kench,et al.  Visceral fat: A key mediator of steatohepatitis in metabolic liver disease , 2008, Hepatology.

[85]  A. Sonmez,et al.  Adipokines and cytokines in non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.

[86]  Ja-june Jang,et al.  Visceral adipose tissue area is an independent risk factor for hepatic steatosis , 2008, Journal of gastroenterology and hepatology.

[87]  A. Baranova,et al.  Adipokines and cytokines in non‐alcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.

[88]  Arya M. Sharma,et al.  Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue—Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism , 2007 .

[89]  S. Kersten,et al.  PPARs, Obesity, and Inflammation , 2006, PPAR research.

[90]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[91]  T. Mendoza,et al.  Changes in Gene Expression Foreshadow Diet-Induced Obesity in Genetically Identical Mice , 2006, PLoS Genetics.

[92]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[93]  C. Mantzoros,et al.  Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. , 2003, Obesity research.

[94]  A. Garg,et al.  Hepatic steatosis, insulin resistance, and adipose tissue disorders. , 2002, The Journal of clinical endocrinology and metabolism.

[95]  H. Gin,et al.  Relationship between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha gene expression in obese human adipose tissue , 2002, International Journal of Obesity.

[96]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[97]  Havva Sezer,et al.  Insulin Resistance, Obesity and Lipotoxicity. , 2017, Advances in experimental medicine and biology.

[98]  Michael Roden,et al.  NAFLD and diabetes mellitus , 2017, Nature Reviews Gastroenterology &Hepatology.

[99]  Zhengai Xiong,et al.  Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans. , 2013, The Journal of clinical endocrinology and metabolism.

[100]  M. Pagliassotti,et al.  2012 Landes Bioscience. Do not distribute. Metabolic alterations following visceral fat removal and expansion Beyond anatomic location , 2012 .

[101]  D. Nicholls,et al.  Thermogenic mechanisms in brown fat. , 1984, Physiological reviews.